Skip to content Skip to left sidebar Skip to footer


Recommend HPV Vaccine at Every Visit!

Recommend HPV Vaccine at Every Visit!

During the first year of the COVID-19 pandemic, there was a decrease in HPV doses administered in the United States.

Here in Philadelphia, there was a 29% decrease in the total number of HPV doses administered in 2020 compared to 2019. This decrease affected every eligible age group:

  • 9-13 year olds: HPV doses administered decreased by 17.5% from 2019 to 2020.
  • 13-17 year olds: HPV doses administered decreased by 41.7% from 2019 to 2020.
  • 18-26 year olds: HPV doses administered decreased by 53.7% from 2019 to 2020.

March 4 is International HPV Awareness Day!

To help bring HPV vaccination rates back to pre-pandemic levels, recommend HPV vaccine at every visit for 9-26 year olds who have not begun or completed their series. 

Register for this CME webinar on March 2 from 1-2pm EST! Dr. Danielle Casher (Attending Physician, Children’s Hospital of Philadelphia) will join cancer survivor Megan Lesar to discuss improving HPV vaccine rates in Pennsylvania.

On March 4, watch and share this video from the Association of Immunization Managers (AIM) to promote timely, complete HPV vaccination.

Steps to Recommend HPV Vaccine to Hesitant Parents


  • Your child is __ years old.
  • Today, they are eligible to receive Tdap, HPV, and MCV vaccine.
  • We will make sure they get all these shots to keep them safe and healthy.

If parent hesitates:

Connect and Counsel:

  • What’s your main concern?
  • Counsel using a research-tested method (ex.”Over 30,000 Americans get cancer from HPV every year. Most could be prevented with the HPV vaccine.”)

If parent declines:

Try Again

  • Almost 70% of parents who initially declined later agree to HPV vaccine or plan to vaccinate soon.




Have questions? Reach out to our team at Thank you for all that you do to keep Philadelphia safe and healthy!

Younger Pediatric COVID-19 Vaccine Coming Soon!

Younger Pediatric COVID-19 Vaccine Coming Soon!

The COVID-19 vaccine for children 6 months through 4 years of age is expected to be approved as early as the end of February.

We need your help as trusted providers to ensure these children have access to vaccination.

Here’s why:

  • To ensure access. Children under 3 cannot be vaccinated in pharmacies and will have limited options of where to seek vaccination.
  • To meet a real need. Nationally, 70% of parents with kids in this age group are ready or close to ready to having their children vaccinated against COVID-19.
  • Parents trust you. The vast majority of these parents would prefer to take their children to their regular provider to be vaccinated.

Your practice is key to vaccinating these younger children.

Click below to watch a video statement from Philadelphia Health Commissioner, Cheryl Bettigole, on the importance of this initiative.

What Can Your Practice Do to Be Ready?

Enroll: If you have not already enrolled, enroll now in the COVID-19 vaccine distribution program.

Spread the word: Let your families know you will be offering COVID-19 vaccine as soon as it becomes available. Order COVID-19 outreach materials (stickers, buttons, posters) at no cost to your practice.

Order: Order vaccine early and often.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email

2022-2023 Flu Season Changes and Survey

2022-2023 Flu Season Changes and Survey

Flu Season Planning Survey

Please complete our 2022-23 Flu Season Planning Survey by Friday, 1/21. Your responses are key in our planning for the next flu season.

Take the Survey

Changes for the 2022-2023 Flu Season

The FDA recently approved the expansion of the age range for a cell based manufactured vaccine, Flucelvax. Under this expansion Flucelvax can be administered to individuals 6 months of age and older.

The flu viruses used in the cell-based vaccines are grown in cultured cells of mammalian origin instead of in hens’ eggs. Most inactivated flu vaccines are produced by growing flu viruses in eggs.

Cell-based flu vaccine production does not use flu viruses grown in eggs and, therefore, is not dependent on the supply of eggs. In addition, cell-based flu vaccines have the potential to offer better protection than traditional, egg-based flu vaccines.

The viruses used to make cell-based vaccines may be more similar to circulating “wild” flu viruses than the viruses used to make egg-based vaccines. Growing flu viruses in eggs can introduce changes (called egg-adapted changes) that can cause differences between the viruses in the vaccine and the ones that are circulating. These changes may have important implications for the body’s immune response to vaccination. For example, egg-adapted changes could cause the body’s immune system to produce antibodies that are less effective at preventing disease caused by the specific flu viruses in circulation.

You can find more information about the types of flu vaccines approved for use in the US on the CDC website here:
Flu Vaccines:
Recombinant Flu Vaccines:
Cell-Based Vaccines:
Flucelax Package Insert:

Storage Unit Reminder

Storage Unit Reminder

Vaccines can only be stored in certain acceptable storage units. Your vaccine storage unit is a key component in maintaining the vaccine cold chain at your practice.

Your vaccine storage units must:

  • Consistently maintain storage temperature.
  • Have enough space to properly store vaccines throughout the year including back to school and flu season.
  • Have separate external doors for refrigerator and freezer.
  • Have Do Not Unplug stickers at the outlet, on unit, and on the circuit breaker.
  • Order Do Not Unplug stickers here.

All units must be plugged directly into a dedicated wall outlet. Units cannot be plugged into:

  • GFI/GFCI outlets (specialized outlets with a built-in breaker, may have reset buttons)
  • Outlets that can be activated by a wall switch
  • Extension cords, power strips, surge protectors
  • Ensure that the unit, plug, and circuit breaker on the electric panel are clearly labeled to prevent accidental loss of power.

Selecting a unit to store your vaccines in is an important decision.

Purchasing a unit that is reliable and accurate up-front is a worthwhile investment, both in time and money, for your practice. The time needed to respond to out of range temperatures and the cost of reimbursement for wasted vaccines can be very burdensome for practices whose unit does not maintain in-range temperatures.

To ensure that the unit that you are considering is the best option for your clinic, email our program at so that we can offer insight on the units that are being considered based on other providers experiences with a brand, the typical supply on hand at your practice, and other considerations based on the CDC recommendations for storage units.

Pfizer “Tris Product” Shelf-Life Extension

Pfizer “Tris Product” Shelf-Life Extension

FDA has approved a shelf-life extension for the Pfizer Pediatric vaccine (orange cap, 5-11 years old, diluent required) and the soon-to-be available Adol/Adult Tris (gray cap, age 12+, no diluent). The expiration date for Pfizer orange and gray cap vaccine has now been extended to 9 months (while held at ULT, or ultra-low temperatures). This approval takes effect immediately. This extension applies to frozen, ultra-low temperature (ULT) inventories only.

Details about this extension may be found in the updated facts sheets, accessible here: Healthcare Providers for 5-11 years of age, orange cap (must dilute); Healthcare Providers for 12 years of age and older, gray cap (no dilution). The Fact Sheets for both orange and gray cap vials provided by the FDA now reads, “regardless of storage conditions, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons.”

As you are aware, the date printed on the Pfizer Pediatric (orange cap) and Adult/Adolescent (gray cap, 12+, no diluent) vaccine vials indicate the manufacture date and NOT the expiration date. The updated expiry dates for both the orange and gray cap vials based on 9 months from the date of manufacture are provided below.

The QR code provided on the Pfizer Pediatric Vaccine carton provides a link to the EUA but does not provide information on expiration dates.

Please follow EUA recommendations for storage:

Pfizer Pediatric vaccine (orange cap, 5-11 years old, diluent required):
• If not previously thawed at 2ºC to 8ºC (35ºF to 46ºF), allow vials to thaw at room temperature [up to 25ºC (77ºF)] for 30 minutes.
• Pfizer-BioNTech COVID-19 vaccine multiple dose vials with orange caps and labels with orange borders may be stored at room temperature [8°C to 25°C (46°F to 77°F)] for a total of 12 hours prior to dilution.
• After dilution, the vial should be held between 2ºC to 25°C (35°F to 77°F). Vials should be discarded 12 hours after dilution.

Adol/Adult Tris (gray cap, age 12+, no diluent) formulation:
• Frozen vials may be stored in an ultra-low temperature freezer at -90ºC to -60ºC (-130ºF to -76ºF). Do not store vials at -25°C to -15°C (-13°F to 5°F). Once vials are thawed, they should not be refrozen.
• Vials may be transferred to the refrigerator [2ºC to 8ºC (35ºF to 46ºF)], thawed and stored for up to 10 weeks. The 10-week refrigerated expiry date should be recorded on the carton at the time of transfer. A carton of 10 vials may take up to 6 hours to thaw at this temperature.

Regardless of storage condition, vaccines should not be used after 9 months from the date of manufacture printed on the vial and cartons.

All Pfizer updated Fact Sheets may be found using the following links:

Pfizer-BioNTech Fact Sheets (English) and FAQs

Provider Fact Sheet: 5-11 years of age, orange cap (must dilute)

Provider Fact Sheet: 12 years of age and older, gray cap (no dilution)

Vaccine Shipment Delays During the Holiday Season

Vaccine Shipment Delays During the Holiday Season

Submit orders by Tuesday, December 7.

During the holiday season – from mid-December to early January – the distribution center that ships vaccine provided through the Vaccines for Children (VFC) and Vaccines for Adults At Risk (VFAAR) programs will have reduced shipping capacity. Orders submitted during this time will take longer than usual to ship.

To make sure that you have the vaccines you need during this time, submit orders by 3:00 PM on Tuesday, December 7. These will be processed and shipped out as usual. Be sure to check the status of your order within 2 business days of submitting.

Continue to check for tracking information daily as FedEx and UPS shipping delays continue. Use this job aid to assist you with reviewing this information.

Orders submitted after Tuesday, December 7 may not be delivered until the week of January 3, at the earliestThe distribution center will return to normal operations on January 3.

For assistance with completing your reconciliation or submitting your order, email:

Provider Education Coordinator

Vaccine Order Specialist
Christine Wilson

Vaccine Order Specialist
Charma Miller

CDC Recommends Pediatric COVID-19 Vaccine for 5-11 Year Olds

CDC Recommends Pediatric COVID-19 Vaccine for 5-11 Year Olds

Today, the Centers for Disease Control (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation that children ages 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine. The Philadelphia Department of Public Health (PDPH) asks all providers to begin vaccinating patients in this group as soon as possible.

All sites must finish ordering pediatric vaccine by 5PM today to ensure delivery next week. All pediatric orders must be submitted with a temperature log and closed reconciliation. If you are having trouble ordering, please email

Ordering Information

To order doses for your 5-11-year-old patients:

  • Complete our interest survey
  • Complete a reconciliation
  • Submit your temperature data
  • Submit an order for the 5-11 patient doses in PhilaVax. Presentation is entered as “Pfizer COVID19 MRNA 5-11 years of age 10mcg/0.2ml”
  • Order minimum of 300 doses and must be in mutiples of 300 (ie. 300, 600, etc)

All steps must be completed by Wednesday November 3rd at 5pm.

Please note: Approved sites will be able to order Pfizer’s 5-11 Pediatric COVID-19 Vaccine each week. Sites will not need to order overstock.

Have Questions?

Have questions about Pfizer’s new formula? Need assistance with the reconciliation process or completing the survey? You can contact us at!
Thank for you helping keep Philadelphia safe and healthy! Together we can stop COVID-19!

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhalls

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhalls

The Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhall will provide an overview of how to prepare and order pediatric COVID-19 Vaccine for the upcoming authorization of Pfizer for 5-11 year olds.

The training will occur multiple times a week:

  • 10/27/2021 Wednesday at 12PM and 5PM
  • 10/28/2021 Thursday at 12PM and 5PM
  • 10/29/2021 Friday at 12PM 
  • 11/02/2021 Tuesday at 12PM and 5PM
  • 11/04/2021 Thursday at 12PM and 5PM
  • 11/09/2021 Tuesday at 12PM and 5PM
  • 11/10/2021 Wednesday at 12PM 
  • 11/16/2021 Tuesday at 5PM 
  • 11/17/2021 Wednesday at 12PM 
  • 11/18/2021 Thursday at 5PM 

Pfizer for Peds 5-11 / COVID-19 Vaccine Management Townhall 

Please join my meeting from your computer, tablet or smartphone.

Webinar Link:

You can also dial in using your phone.
United States: +1 (408) 650-3123

Access Code: 532-390-413

Join from a video-conferencing room or system.
Dial in or type: or
Meeting ID: 532 390 413
Or dial directly: 532390413@ or

New to GoToMeeting?
Get the app now and be ready when your first meeting starts:

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email

CDC Clinician Outreach and Communication Activity (COCA) Call on 9/9/2021

CDC Clinician Outreach and Communication Activity (COCA) Call on 9/9/2021

The Centers for Disease Control and Prevention (CDC) has announced a Clinician Outreach and Communication Activity (COCA) Call.

When: September 9th at 2pm EDT.

Topic: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

Meeting link:

Webinar ID: 161 045 6908

Passcode: 220280

Click here to join the CDC Coca Call!

During this COCA Call, presenters will provide updates on the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2021-2022 influenza vaccination season and guidance for coadministration of influenza and COVID-19 vaccines.

There will be a web on-demand version of the call available after the live event.

Please click here to access additional COCA calls and other training from CDC, the World Health Organization, and other training providers.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email

Additional VFC Flu Vaccine Presentations Available to Order

Additional VFC Flu Vaccine Presentations Available to Order

FluMist intranasal sprayers and Fluzone multidose vials are now available to order for your VFC patients.

Please refer to the flu ordering guide for the full product information for these vaccines.

As a reminder, all flu vaccine from the 2020-2021 season must be accounted for before you can order flu for the 2021-2022 season. Guidance on accounting for remaining doses can be found here.

Order Flu Vaccine Today!

Have questions?

Contact Christine Wilson at 215.685.6728 or, or Charma Miller at 215.685.6667 or for assistance.

Thank you for keeping Philadelphia healthy by fighting flu! For more information about influenza in Philadelphia, visit our flu page.